Search
for
Sort by
Research 121–150 of 1000+
- Effect of Cuscuta reflexa Extract in Mitigating Testosterone-Induced Benign Prostatic Hyperplasia in Rats: Targeting Inflammation and Oxidative Stress
- Hétérogénéité tumorale du cancer de la prostate et infection par le SARS-CoV2 : une relation complexe impliquant les vésicules extracellulaires et le récepteur des androgènes
- Causal associations between plasma proteins and prostate cancer: a Proteome-Wide Mendelian Randomization
- The Risks and Benefits of 5α-Reductase Inhibitors for Prostate-Cancer Prevention
- Male pattern baldness and the risk of prostate cancer
- The relation between androgenetic thin hair diagnosed by trichoscope and benign prostatic hyperplasia
- The Experience of SARS-CoV-2 in Patients with Benign Prostatic Hyperplasia: Is There Any Correlation between Them?
- Changes in hair weight in men with androgenetic alopecia after treatment with finasteride (1 mg daily): Three- and 4-year results
- 5-Alpha Reductase Inhibitors in Prostate Cancer: From Clinical Trials to Clinical Practice
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction
- Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia
- Analysis of Data From Breast Diseases Treated With 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia
- UTILIZAÇÃO DE FINASTERIDA NO TRATAMENTO DA HIPERPLASIA PROSTÁTICA BENIGNA – RELATO DE CASO
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Thrombocytosis Associated with Low-Molecular-Weight Heparin
- 5α- Reductase Inhibitors in Prostate Cancer: An Overview
- Risk factors for prostate cancer: a case-control study investigating selected key exposures and their interactions with predisposition genes
- Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients
- Five-alpha-reductase Inhibitors for prostate cancer prevention.
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- Early-onset baldness and the risk of aggressive prostate cancer: findings from a case–control study
- Vitamin D, Lipid Metabolism and Prostate Cancer
- Development of a Doxazosin and Finasteride Transdermal System for Combination Therapy of Benign Prostatic Hyperplasia
- Does Androgenic Alopecia Aggravate the Risk of Prostate Cancer? Evidence from Mendelian Randomization
- Liarozole—a novel treatment approach for advanced prostate cancer: results of a large randomized trial versus cyproterone acetate
- Redefining hormone resistance in prostate cancer
- Intermittent Use of Testosterone Inactivating Pharmaceuticals Using Finasteride Prolongs the Time Off Period
- Corn silk extract improves benign prostatic hyperplasia in experimental rat model